SCHEMBL18017665

SCHEMBL18017665

c1ccc(-c2nc(-c3cccc(-c4nc(-c5ccccc5)nc5c4sc4ccccc45)c3)c3sc4ccccc4c3n2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TNKS O95271 3/20 0.39
▸ TNKS2 Q9H2K2 3/20 0.39
▸ ADORA2A P29274 1/20 0.38
▸ ADORA1 P30542 1/20 0.38
▸ LIMK1 P53667 3/20 0.38
▸ CDK5 Q00535 1/20 0.38
▸ CDK5R1 Q15078 1/20 0.38
▸ MEN1 O00255 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ ATM Q13315 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ PIK3CA P42336 1/20 0.36
▸ PIM1 P11309 1/20 0.36
▸ PIM2 Q9P1W9 1/20 0.36
▸ KRAS P01116 1/20 0.36
▸ DPP4 P27487 3/20 0.35
▸ HRH4 Q9H3N8 1/20 0.35
▸ WHR1 P49842 1/20 0.35
▸ ALOX5 P09917 1/20 0.35
▸ EGFR P00533 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18017724 0.99 TNKS (0.38) TNKSTNKS2ADORA2AADORA1LIMK1
SCHEMBL18017674 0.99 TNKS (0.38) TNKSTNKS2ADORA2AADORA1LIMK1
SCHEMBL18017649 0.99 TNKS (0.38) TNKSTNKS2ADORA2AADORA1LIMK1
SCHEMBL16902228 0.97 LIMK1 (0.39) TNKSTNKS2ADORA2AADORA1LIMK1
SCHEMBL18017910 0.97 TNKS (0.40) TNKSTNKS2ADORA2AADORA1LIMK1
SCHEMBL18158353 0.97 MEN1 (0.38) TNKSTNKS2ADORA2AADORA1LIMK1
SCHEMBL18017647 0.97 WHR1 (0.39) TNKSTNKS2ADORA2AADORA1LIMK1
SCHEMBL18017723 0.96 WHR1 (0.38) TNKSTNKS2ADORA2AADORA1LIMK1
SCHEMBL16902217 0.96 LIMK1 (0.41) TNKSTNKS2ADORA2AADORA1LIMK1
SCHEMBL18158373 0.96 MEN1 (0.38) TNKSTNKS2ADORA2AADORA1LIMK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160240791-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2016-08-18 — — US disclosed
US-20160240791-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2016-08-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160240791-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE OR10J3, OXER1, OCIAD1 TNKS 4644/4885TNKS2 4726/4885ADORA2A 3675/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback